Altus Pharmaceuticals: Clinical Trials

1 completed, 1 unknown. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 1, Unknown 1

Follow Altus Pharmaceuticals: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency Somatropin - Growth Hormone Deficiency	Phase 2	Unknown	Altus Pharmaceuticals	36	2009-03-01	2009-05-07
Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety ALTU-238 - Adult Growth Hormone Deficiency	Phase 2	Completed	Altus Pharmaceuticals	12	2005-07-01	2006-12-13

Conditions studied

Dwarfism, Pituitary (2)

Interventions

Human Growth Hormone (1)

Countries

United States (2)